DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 85 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,251,000 | +38.9% | 855,713 | +157.2% | 1.04% | +52.2% |
Q2 2021 | $12,417,000 | +46.0% | 332,713 | 0.0% | 0.68% | +41.0% |
Q1 2021 | $8,507,000 | +16.4% | 332,713 | +0.3% | 0.48% | +26.6% |
Q4 2020 | $7,310,000 | +22.5% | 331,813 | 0.0% | 0.38% | +16.8% |
Q3 2020 | $5,969,000 | -29.2% | 331,813 | 0.0% | 0.33% | -35.2% |
Q2 2020 | $8,428,000 | +38.3% | 331,813 | 0.0% | 0.51% | -0.8% |
Q1 2020 | $6,095,000 | -16.6% | 331,813 | 0.0% | 0.51% | +26.9% |
Q4 2019 | $7,310,000 | +53.4% | 331,813 | 0.0% | 0.40% | +26.8% |
Q3 2019 | $4,765,000 | -8.8% | 331,813 | 0.0% | 0.32% | +24.8% |
Q2 2019 | $5,226,000 | -28.8% | 331,813 | -33.8% | 0.25% | -17.0% |
Q1 2019 | $7,338,000 | +37.0% | 500,913 | 0.0% | 0.31% | +7.4% |
Q4 2018 | $5,355,000 | -29.9% | 500,913 | 0.0% | 0.28% | -7.8% |
Q3 2018 | $7,644,000 | +24.6% | 500,913 | 0.0% | 0.31% | +26.1% |
Q2 2018 | $6,136,000 | +28.1% | 500,913 | 0.0% | 0.24% | +19.5% |
Q1 2018 | $4,789,000 | +5.9% | 500,913 | 0.0% | 0.20% | +5.1% |
Q4 2017 | $4,523,000 | +57.0% | 500,913 | 0.0% | 0.20% | +61.2% |
Q3 2017 | $2,880,000 | +81.4% | 500,913 | 0.0% | 0.12% | +63.5% |
Q2 2017 | $1,588,000 | -3.0% | 500,913 | +4.0% | 0.07% | -3.9% |
Q1 2017 | $1,637,000 | +259.0% | 481,519 | +204.2% | 0.08% | +196.2% |
Q4 2016 | $456,000 | -71.0% | 158,279 | -40.9% | 0.03% | -71.4% |
Q3 2016 | $1,575,000 | +95.9% | 267,890 | 0.0% | 0.09% | +49.2% |
Q2 2016 | $804,000 | -44.0% | 267,890 | 0.0% | 0.06% | -45.0% |
Q1 2016 | $1,436,000 | -54.8% | 267,890 | 0.0% | 0.11% | -37.3% |
Q4 2015 | $3,180,000 | +44.6% | 267,890 | 0.0% | 0.18% | +67.0% |
Q3 2015 | $2,199,000 | +123.0% | 267,890 | +278.9% | 0.11% | +140.9% |
Q2 2015 | $986,000 | – | 70,706 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |